Summary
Free radical mechanisms are increasingly being implicated in the pathogenesis of tissue damage in diabetes. Various sources of free radicals may modulate oxidative stress in diabetes, including non-enzymatic glycosylation of proteins and monosaccharide autooxidation, polyol pathway activity, indirect production of free radicals through cell damage from other causes, and reduced antioxidant reserve. Ascorbic acid, which may be a principal modulator of free radical activity in diabetes, is shown to be consumed, presumably through free radical scavenging, thus preserving levels of other antioxidants such as glutathione.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Arai, K., lizuka, S., Tada, Y., Oikawa, K., and Taniguchi, N. (1987) Increase in the glycosylated form of erythrocyte Cu-Zn-SOD in diabetes and close association of non-en- zymic glycosylation with enzyme activity. Biochim. Biophys. Acta. 924: 292–296.
Asayama, K., Kooy, N. W., and Burr, I. M. (1986) Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. J. Lab. Qin. Med. 107: 459–464.
Awadalla, R., El-Dessoukey, E. A., Doss, H., and Klalifa, K. (1978) Blood-reduced glutathione, serum caeruloplasmin and mineral changes in juvenile diabetes. Z. Er- nahrungsweiss. 17: 72–78.
Banjerjee, A. (1982) Blood dehydroascorbic acid and diabetes mellitus in human beings. Ann. Clin. Biochem. 19: 65–70.
Barnes, M. J. (1976) Function of ascorbic acid in collagen metabolism. Ann. N. Y. Acad. Sci. 258: 264–275.
Betteridge, D. J. (1989) Diabetes, Lipoprotein metabolism and atherosclerosis. Br. Med. Bull. 45: 285–311.
Bradley, B., Prowse, S. J., Bauling, P., and Lafferty, K. J. (1986) Desferrioxamine treatment prevents chronic islet allograft damage. Diabetes 35: 550–555.
Brownlee, M., Cerami, A., and Vlassara, H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med 318: 1315–1321.
Caird, F. I. (1982) Complications of diabetes in old age, in: Advanced Geriatric Medicine. Evans, J. G. and Caird, F. I. eds. Pitman, London, pp. 3–9.
Cerami, A. (1986) Ageing of proteins and nuclei acids. What is the role of glucose? Trends Biol. Sci. 11: 311–314.
Chari, S. W., Nath, N., and Rathi, A. B. (1984) Glutathione and its redox system in diabetic polymorphonuclear leucocytes. Am. J. Med. Sci. 287: 14–15.
Cogan, D. G. (1984) Aldose reductase and complications of diabetes. Ann. Intern. Med. 101: 82–91.
Collier, A., Jackson, M., Dawkes, R. M., Bell, D., and Clarke, B. F. (1988) Reduced free radical activity detected by decreased diene conjugates in insulin-dependent diabetic patients. Diabetic Med. 5: 747–749.
Collier, A., Wilson, R., Bradley, H., Thomson, J. A., and Small, M. (1989) Free radical activity in type 2 diabetes. Diabetic Med. 7: 27–30.
Collier, A., and Small, M. (1991) The role of the polypol pathway in diabetes mellitus. Br. J. Hosp. Med. 45: 38–40.
Cox B. D., and Butterfield, W. J. H. (1975) Vitamin C supplements and diabetic cutaneous capillary fragihty. Br. Med. J. 3: 205.
Crary, E. J., and McCarty, M. F. (1984) Potential clinical applications for high dose nutritional antioxidants. Med. Hypothesis. 13: 77–98.
Davis, K. A., Lee, W. Y. L., and Labbe, R. F. (1983) Energy dependent transport of ascorbic acid into lymphocytes. Fed Proc. 42: 2011.
Dinarello, C. A. (1986) Interleuken-l:amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachetin). Year Immunol. 2: 68–89.
Greene, D. A., Lattimer, S. A., and Sima, A. A. F. (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic comphcations. N. Engl. J. Med. 316: 599–606.
Halliewll, B., and Gutteridge, J. M. C. (1984) Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet, I: 1396–1397.
Herman, J. B., Medalie, J. H., and Goldbourt, U. (1976) Diabetes, prediabetes and uricaemia. Diabetolagra 12: 47–52.
Hunt, J. v., and Wolff, S. P. (1991) Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Rad. Res. Comms. 12/13: 115–123.
Ilhng, E. K., Gray, C. H., and Lawrence, R. D. (1951) Blood glutathione and non-glucose substances in diabetes. Biochem. J. 48: 637–640.
Jones, A. F., Winkles, J. W., Jennings, P. E., Florkowski, C. M., Lunec, J., and Bamett, A. H. (1988) Serum antioxidant activity in diabetes meUitus. Diabetes Res. 7: 89–92.
Karpen, C. W., Cataland, S., and O’Dorisio, T. M. (1985) Production of 12 HETE and vitamin E status in platelets from type 1 human diabetic subjects. Diabetes 34: 526–531.
Kirstein, M., Brett, J., Radoff, S., Ogawa, S., Stem, D., and Vlassara, H. (1990) Advanced protein glycosylation induces transendothehal human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and ageing. Proc. Natl. Acad. Sci. 87: 9010–9014.
Levine, M. (1986) New concepts in the biology and biochemistry of ascorbic acid. N. Eng. J. Med. 314: 892–902.
Makita, Z., Radoff, S., Rayiield, E. J., Yang, Z., Skolnik, E., Delaney, V., Friedman, E. A., Cerami, A., and Vlassara, H. Advanced glycosylation end products in patients with diabetic nephropathy. New Engl. J. Med. 325: 836–842.
Malaisse, W. J. (1982) Alloxan toxicity to the pancreatic beta-cell: a new hypothesis. Biochem. Pharmacol. 31: 3527–3534.
Matkovics, B., Varga, S., and Seabo, L. (1982) The effect of diabetes on the activity of the peroxide metabohsing enzymes. Horm. Metab. Res. 14: 77–79.
Matsubara, T., and Ziff, M. (1986) Increased superoxide anion from human endothehal cells in response to cytokines, J. Immunol. 137: 3295–3298.
McLennan, S., Yue, D. K., Fisher, E., Capogreco, C., Heffernan, S., Ross, G. R., and Turtle, J. R. (1988) Deficiency of ascorbic acid in experimental diabetes: relationship with collagen and polyol pathway abnormahties. Diabetes 37: 359–361.
Monnier, V. M., Kohn, R. R., and Cerami, A. (1984) Accelerated age-related browning of human collagen in diabetes melhtus. Proc. Natl. Acad. Sci. 81: 583–587.
Neale, R. J., Lim, H., Turner, J., and Freeman, J. R. (1988) The excretion of large vitamin C loads in young and elderly subjects: an ascorbic acid tolerance test. Age and Ageing 17: 35–41.
Nerup, J., Mandrup-Poulson, T., Molvig, J., Helqvist, S., Wogensen, L., and Egeberg, J. (1988) Mechanisms of pancreatic beta-cell destruction in type 1 diabetes. Diabetes Care 11: 16–23.
Nishigaki, L, Hagihara, M., Tsunekawa, H., Maseki, M., and Yagi, K. (1981) Lipid peroxide levels of serum hpoprotein fractions of diabetic patients. Biochem. Med. 25: 373–378.
Nomikos, I. N., Prowse, S. J., Carotenuto, P., and Lafferty, K. J. (1986) Combined treatment with nicotinamide and desferrioxamine prevents islet aUograft destruction in NOD mice. Diabetes 35: 1302–1304.
Pincus, S. H., Whitcomb, E. A., and Dinarelio, C. A. (1986) Interaction of IL-1 and TPA in modulation of eosinophil function. J. Immunol. 137: 3509–3514.
Procter, P. H., and Reynolds, E. S. (1984) Free radicals and disease in man. Physiol. Chem. Phys. 16: 175–195.
Rikans, L. E. (1981) Effect of alloxan diabetes on rat ascorbic acid. Horm. Metab. Res. 13: 123.
Sacks, T., Moldow, C. F., Craddock, P. R., Bowers, T. K., and Jacob, H. S. (1978) Oxygen radicals mediate endothehal ceh damage by complement-stimulated granulocytes. J. Chn. Invest. 61: 1161–1167.
Salonen, J. T., Salonen, R., Ihanainen, M., Parviainen, M., Seppanen, R., Kantola, M., Seppanen, K., and Rauramaa, R. (1988) Blood pressure, dietary fats, and antioxidants. Am. J. Chn. Nutr. 48: 1226–1232.
Sato, Y., Hotta, N., Sakamoto, N., Matsuoka, S., Ohishi, N., and Yagi, K. (1979) Lipid peroxide level in plasma of diabetic patients. Biochem. Med. 21: 104–107.
Seltzer, H. S. (1957) Blood glutathione in mild diabetes melUtus before treatment and during sulphonylurea-induced hypoglycaemia. Proc. Soc. Exp. Biol. Med. 95: 74–76.
Selwign, A. P. (1983) The cardiovascular system and radiation. Lancet 2: 152–154.
Siperstein, M. D., Unger, R. H., and Madison, L. L. (1968) Studies of muscle capillary basement membranes in normal subjects, diabetic and pre-diabetic patients. J. Clin. Invest. 47: 1973–1999.
Som, S., Basu, S., Mukherjee, D., Deb S., Choudary, R., Mukherjee, S., Chatterjee, S. N., and Chatterjee, L B. (1981) Ascorbic acid metabolism in diabetes mellitus. Metabolism 30: 572–577.
Sinclair, A. J., Lunec, J., and Barnett, A. H. (1989). Diene conjugates and microangiopathy. Diabetic Med. 6: 458.
Sinclair, A. J., Girling, A. J., Gray, L., Le Guen, C., Lunec, J., and Barnett, A. H. (1991) Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation. Diabetologia 34: 171–175.
Sinclair, A. J., Girling, A. J., Gray, L., Lunec, J., and Barnett, A. H. (1992) An investigation of the relationship between free radical activity and vitamin C metaboUsm in elderly diabetic subjects with retinopathy. Gerontology (in press).
Steinbrecher, U. P., Parthasarathy, S., Leake, D. S., Witztum, J. L., and Steinberg, D. (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. 81: 3883–3887.
Stringer, M. D., Gorog, P. G., Freeman, A., and Kakkar, V. V. (1989) Lipid peroxides and atherosclerosis. Br. Med. J. 298: 281–284.
Thomas, G., Skrinska, V., Lucas, F. V., and Schumacher, O. P. (1985) Platelet glutathione and thromboxane synthesis in diabetes. Diabetes 34: 951–954.
Trabser, M. G., and Kayden, H. J. (1980) Low density lipoprotein receptor activity in human monocyte-derived macrophages and its relation to atheromatous lesions. Proc. Natl Acad. Sci. 77: 5466–5470.
Vlassara, H., Brownlee, M., Manogue, K., Dinarello, C., and Pasagian, A. (1988) Cachectin/ TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelling. Science 204: 1546–1548.
Ward, P. A., Till, G. O., Kunkel, R., and Beauchamp, G. (1983) Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury. J. Clin. Invest. 72: 789–801.
Yamada, K., Nonaka, K., Hanafusa, T., Miyazaki, A., Toyoshima, H., and Tarui, S. (1982) Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insuHtis: an observation in nonobese diabetic (NOD) mice. Diabetes 31: 749–753.
Yew, M. S. (1983) Effect of streptozocin diabetes on tissue absorbic acid and dehydroascorbic acid. Horm. Metab. Res. 15: 158.
Yue, D. K., McLennan, S., Fischer, E., Heffernan, S., Capogreco, C., Ross, G. R., and Turtle, J. R. (1989) Ascorbic acid metabolism and the polyol pathway. Diabetes 38: 257–261.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Sinclair, A.J., Lunec, J., Girling, A.J., Barnett, A.H. (1992). Modulators of free radical activity in diabetes mellitus: Role of ascorbic acid. In: Emerit, I., Chance, B. (eds) Free Radicals and Aging. EXS, vol 62. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7460-1_34
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7460-1_34
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7462-5
Online ISBN: 978-3-0348-7460-1
eBook Packages: Springer Book Archive